Actively Recruiting
Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer
Led by Peking University People's Hospital · Updated on 2025-05-04
244
Participants Needed
1
Research Sites
217 weeks
Total Duration
On this page
Sponsors
P
Peking University People's Hospital
Lead Sponsor
P
Peking University
Collaborating Sponsor
AI-Summary
What this Trial Is About
To construct a prediction model of progesterone sensitivity in patients with endometrial cancer treated with fertility preservation
CONDITIONS
Official Title
Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis by hysteroscopy of atypical endometrial hyperplasia or well-differentiated early endometrial carcinoma grade 1 without myometrial invasion
- No signs of suspected extrauterine involvement on enhanced MRI, CT, or ultrasound
- Desire to preserve reproductive function or uterus
- Good compliance with treatment and follow-up
You will not qualify if you...
- Acute liver disease, liver tumor, or kidney dysfunction
- Pregnancy or potential pregnancy
- Diagnosis of any cancer in the reproductive system
- Acute severe disease such as stroke, heart attack, or history of thrombosis
- Allergy or contraindication to Medroxyprogesterone acetate (MPA) or Megestrol acetate (MA)
- Other reproductive dysfunction factors
- Strong desire for uterine removal or alternative conservative treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University People's Hospital
Beijing, Beijing Municipality, China
Actively Recruiting
Research Team
W
WANG JIANLIU, PhD/MD
CONTACT
H
HE YIJIAO, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here